• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Sheldon Razin, Founder of NextGen Healthcare, Issues Statement with Respect to 2021 Annual Meeting

    10/13/21 12:36:00 PM ET
    $NXGN
    EDP Services
    Technology
    Get the next $NXGN alert in real time by email

    Sheldon Razin, the founder of NextGen Healthcare, Inc. (NASDAQ:NXGN) and its largest shareholder, issued the following statement with respect to the Company's 2021 Annual Meeting held today:

    On behalf of the Razin Group, I thank shareholders for their engagement over these past weeks.

    As the Company's founder and largest shareholder, I am proud of the growth and market expansion that the Company has achieved, and wish NextGen Healthcare's Board of Directors and management team success going forward.

    NextGen Healthcare has an outstanding portfolio of products and services that have transformed ambulatory care. With the appointment of the Company's new CEO, David Sides, and the talented and dedicated team across the organization, I believe NextGen Healthcare is well positioned to build on its market leadership.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211013005964/en/

    Get the next $NXGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NXGN

    DatePrice TargetRatingAnalyst
    8/28/2023$21.00Overweight
    Cantor Fitzgerald
    4/12/2023$24.00Overweight
    Stephens
    10/21/2022$20.00Neutral
    Piper Sandler
    9/7/2022$20.00Hold
    Truist
    5/6/2022$26.00Neutral → Buy
    Guggenheim
    4/14/2022Neutral
    Guggenheim
    1/6/2022$22.00Mkt Perform → Outperform
    SVB Leerink
    1/6/2022Market Perform → Outperform
    SVB Leerink
    More analyst ratings